The Ramsay (ASX:RHC) share price lifted 8% last time the company reported

Let's take a look.

| More on:
share price up

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is enjoying a decent day of trading this Wednesday. The ASX 200 is currently up 0.16% to 7,515 points at the time of writing. However, in what might be some trepidation about it's earnings report tomorrow, the Ramsay Health Care Limited (ASX: RHC) share price is not enjoying the same treatment. Ramsay shares are currently trading at the rather unfortunate share price of  $66.66, down 0.48% for the day.

So as I just mentioned, Ramsay is scheduled to report its full-year earnings for FY2021 tomorrow morning. But while we wait with bated breath for these numbers, let's check out what the Ramsay Health Care share price did last time the company had an appointment with its investors.

So Ramsay reported its half-year earnings back in February of this year, 25 February to be precise.

Here's a summary of what the company reported at the time:

  • Revenues of $5.9 billion, a 6.6% fall over the previous corresponding period (pcp).
  • Statutory net profit of $226 million, a 12.5% drop over the pcp.
  • Diluted earnings per share (EPS) came in at 96.9 cents, a decline of 21.1% over the pcp
  • Earnings before interest and tax (EBIT) of $583.8 million, a 4.2% slump.
  • An interim dividend of 48.5 cents per share, fully franked, 21.1% lower than Ramsay's previous interim payout.

How did the Ramsay Health Care share price respond?

Despite these numbers showing a significant hit from the coronavirus outbreak, investors responded enthusiastically to these earnings back in February. As we covered at the time, investors sent Ramsay shares up around 8% in the first few hours of trading following this release. As it stands today, Ramsay shares are around 5.5% higher than the day before this report became public 6 months ago.

At the current Ramsay share price, the company has a market capitalisation of $15.32 billion, a price-to-earnings (P/E) ratio of 62.96 and a dividend yield of 0.72%.

This company is up 6.88% year to date in 2021 so far, but is only up 1.07% over the past 12 months. Disappointingly for its investors, the Ramsay share price is also down close to 12% over the past 5 years.

Motley Fool contributor Sebastian Bowen owns shares of Ramsay Health Care Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Healthcare Shares

Guess which ASX small cap stock is jumping on 'significant milestone'

This stock is ending the week in style. Let's see what is giving its shares a boost today.

Read more »

Healthcare Shares

Are CSL and this ASX 200 healthcare stock buys in January?

Is now a good time to pick up these shares? Let's see what analysts are saying.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Communication Shares

2 ASX shares expected to report strong earnings this quarter

Analysts expect a strong set of upcoming numbers for these ASX heavyweights

Read more »

A women has her eyes checked at the optometrist.
Healthcare Shares

Is Medibank stock a good buy?

Can this company provide healthy returns?

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX healthcare stock is jumping 7% on US FDA approval news

This share is giving its shareholders an early Christmas present.

Read more »

A senior pharmacist talks to a customer at the counter in a shop
Healthcare Shares

Is it too late to buy Sigma shares to cash in on the Chemist Warehouse deal?

Can investors still make healthy returns with this stock?

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Why the Mesoblast share price is diving 18% after an FDA win

Investors are sending the Mesoblast share price tumbling on Friday. But why?

Read more »

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
Healthcare Shares

Mesoblast share price rockets 30% on big US FDA news

Big news is giving this biotech a huge lift on Thursday.

Read more »